Barak L S, Ménard L, Ferguson S S, Colapietro A M, Caron M G
Howard Hughes Medical Institute Laboratories, Duke University Medical Center, Durham, North Carolina 27710, USA.
Biochemistry. 1995 Nov 28;34(47):15407-14. doi: 10.1021/bi00047a003.
The beta 2-adrenergic receptor (beta 2AR) is a member of a large superfamily of seven transmembrane domain, G-protein-coupled receptors. Within the putative seventh transmembrane domain of the beta 2AR is a sequence of amino acids, NPLIY, which is conserved with minor variations in all members of the superfamily. Previously it was demonstrated that mutation of tyrosine residue 326 to an alanine abolished agonist promoted sequestration of this mutant without affecting its ability to maximally stimulate adenylyl cyclase in membranes [Barak, L.S., Tiberi, M., Freedman, N.J., Kwatra, M.M., Lefkowitz, R.J., & Caron M.J. (1994) J Biol. Chem. 269, 2790-2795]. In the present study we characterized the NPLIY amino acid sequence in an attempt to determine how it can affect the agonist-mediated sequestration of the beta 2AR and to test whether it is a functional motif. We find that point mutations of the most conserved amino acids, N, P, and Y, in this sequence affect several other receptor properties in addition to sequestration. Mutation of asparagine 322 to an alanine resulted in complete uncoupling of the receptor, loss of high-affinity agonist binding, and abolition of receptor sequestration, down-regulation, and phosphorylation. In contrast, a conservative mutation of this residue to an aspartic acid (as found in the thrombin receptor) resulted in an improvement of G-protein coupling without adversely affecting other receptor properties. Substitution of proline residue 323 with an alanine residue resulted in a receptor with mild deficits in sequestration and coupling, a reduced agonist-mediated phosphorylation, and no change in down-regulation.(ABSTRACT TRUNCATED AT 250 WORDS)
β2 - 肾上腺素能受体(β2AR)是一个由七个跨膜结构域组成的大型超家族——G蛋白偶联受体的成员。在β2AR假定的第七个跨膜结构域内,有一段氨基酸序列NPLIY,该序列在超家族的所有成员中都保守存在,仅有微小差异。此前有研究表明,将酪氨酸残基326突变为丙氨酸会消除激动剂促进该突变体的隔离作用,同时不影响其在细胞膜中最大程度刺激腺苷酸环化酶的能力[巴拉克,L.S.,蒂贝里,M.,弗里德曼,N.J.,夸特拉,M.M.,莱夫科维茨,R.J.,& 卡隆,M.J.(1994年)《生物化学杂志》269卷,2790 - 2795页]。在本研究中,我们对NPLIY氨基酸序列进行了表征,试图确定它如何影响激动剂介导的β2AR隔离作用,并测试它是否是一个功能基序。我们发现,该序列中最保守的氨基酸N、P和Y的点突变除了影响隔离作用外,还会影响其他几种受体特性。将天冬酰胺322突变为丙氨酸会导致受体完全解偶联,失去高亲和力激动剂结合能力,消除受体隔离、下调和磷酸化作用。相比之下,将该残基保守突变为天冬氨酸(如凝血酶受体中所见)会改善G蛋白偶联,且不会对其他受体特性产生不利影响。将脯氨酸残基323替换为丙氨酸残基会导致受体在隔离和偶联方面有轻微缺陷,激动剂介导的磷酸化作用降低,而下调作用无变化。(摘要截选至250字)